Back to User profile » Dr Kjell Håkansson
Papers published by Dr Kjell Håkansson:
Prevalence, Change and Burden of Systemic Corticosteroid Use in Type 2 Inflammation Associated Diseases Over 25 Years – A Nationwide Danish Study
Håkansson KEJ, Skov IR, Andersen SAW, Ali Z, Løkke A, Ibsen R, Hilberg O, Meteran H, Johnsen CR, Backer V, Ulrik CS
Journal of Asthma and Allergy 2025, 18:967-981
Published Date: 6 June 2025
Childhood Asthma and Parental Antidepressant Use in a Nationwide Danish Cohort
Cabrera Guerrero S, Håkansson KEJ, Backer V, Ulrik CS, Rastogi D
Journal of Asthma and Allergy 2023, 16:821-831
Published Date: 8 August 2023
Disease Control, Not Severity, Drives Job Absenteeism in Young Adults with Asthma – A Nationwide Cohort Study
Håkansson KEJ, Backer V, Ulrik CS
Journal of Asthma and Allergy 2022, 15:827-837
Published Date: 20 June 2022
Determining Persistence with an Inhaled Corticosteroid in Asthma: Assessment Using an Objective Measurement vs the Self-Reported Foster Score
Hedegaard BO, Håkansson KEJ, Jensen FF, Ulrik CS, Weinreich UM
Journal of Asthma and Allergy 2022, 15:25-33
Published Date: 5 January 2022
High Use of Antidepressant Medication in Both Mild-to-Modelate and Possible Severe Asthma – A Nationwide Cohort Study
Håkansson KEJ, Renzi-Lomholt M, Backer V, Ulrik CS
Journal of Asthma and Allergy 2022, 15:13-23
Published Date: 5 January 2022
Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
Damkjær M, Suppli Ulrik C, Godtfredsen N, Håkansson KEJ
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2397-2406
Published Date: 24 August 2021
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]
Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2393-2395
Published Date: 19 August 2021
Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study
Håkansson KEJ, Fjaellegaard K, Browatzki A, Dönmez Sin M, Ulrik CS
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2119-2127
Published Date: 16 July 2021
Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
Damkjær M, Håkansson K, Kallemose T, Ulrik CS, Godtfredsen N
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:579-589
Published Date: 5 March 2021
High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
Håkansson KEJ, Ulrik CS, Godtfredsen NS, Kallemose T, Andersen O, Eugen-Olsen J, Marsaa K, Rasmussen LJH
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:733-743
Published Date: 5 April 2020